Yale Early Stage Ovarian Cancer Detection Technology Licensed By LabCorp®
Sun, 26 Feb 2006 03:00 AM EST
... New Haven, Conn. -- Yale University Office of Cooperative Research today announced that it has granted an exclusive license agreement with Laboratory Corporation of America Holdings (LabCorp) for the commercialization of the university''s blood testing technology for epithelial ovarian cancer (EOC)... click link for more info. ...
Related Topics
- Ovarian Cancer
- Uterine Cancer
- Cervical Cancer
- Assistive Technology
- Testicular Cancer
- Colon Cancer
- Lung Cancer
- Ovarian Cysts
- Cancers
- Oral Cancer
- Brain Cancer
- Pancreatic Cancer
- Liver Cancer
- Metastatic Cancer
- Porfimer Injection
- Small Cell Lung Cancer
- Prostate Cancer
- Cancer
- Kidney Cancer
- Esophageal Cancer

Not Signed In -


